Keywords: cpmp, backs, merck, kgaa, erbitux, germany, says

CPMP backs Merck KGaA's Erbitux

Article | 05 April 2004

Print This

Germany's Merck KGaA says that its metastatic colorectal cancer drug Erbitux (cefuximab) has been recommended for approval by the Committee ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in